Answer

What did the WHI study actually show about HRT?

HRT & Menopause hrt menopause whi breast-cancer

By Arun AgrahriLast reviewed 4 timecoded sources

Short answer

Precis has no verdict: no counted source or study it has read sits on this claim. Speakers on tape, not counted, describe a 24-26% relative rise in breast cancer on estrogen plus progestin. That came to less than one extra case per 1,000 women a year, they say, and estrogen alone showed no rise.

Best for:
women and clinicians weighing HRT who want the WHI results in context.
Price:
Free to read, with every receipt. Pro is $9 a month or $79 a year and adds AI Ask.
Based on what researchers say in public interviews on YouTube. Educational only, not medical advice. Ask a qualified clinician before changing a supplement, medication, treatment, or testing plan.
Leaning for

Hormone therapy around menopause does more good than harm for most women.

The verdict on HRT & Menopause overall. 12 sources: 4 positive, 8 partly

What the evidence says

positive partly neutral negative Each researcher and each study counts once per claim, however often they come up.

  1. Not enough evidence

    The WHI study was misread: HRT added about one extra breast cancer case per 1,000 women a year.

    No counted mention yet.

    Researchers say

    No researcher counted yet.

    Studies show

    No study counted yet.

    17 more not counted · see why

Precis is not affiliated with or endorsed by YouTube or by any researcher, show or publisher we quote. We take no sponsorship, ad or affiliate money, and every verdict is our own review of what was said. How we stay independent

Detailed Answer

No source on tape counts toward this claim yet, and no study Precis has read is on it, so there is no verdict. Seventeen mentions on tape touch it, and none counts: reviewers could not confirm the speaker, the stance or the source, or the remark was a host's. Precis has read studies on related HRT claims, such as whether HRT is safe now and how transdermal and oral estrogen compare, and those pages are linked below.

Everything that follows is on tape but not counted.

Relative and absolute risk

The Women's Health Initiative (WHI) gave women either hormones or a placebo. Sharon Malone, an OB/GYN and guest on Mark Hyman's show, walks through the breast-cancer result for the arm that took estrogen plus a progestin, Premarin and Provera. The trial reported "a 26% increase in the risk of breast cancer," she says.

In real terms, the rate went "from 30 per 10,000 women per year to 38 per 10,000 per year," with no rise in the risk of dying. That is less than one extra case per 1,000 women a year. On Peter Attia's episode with Avrum Bluming, the two note that the first figure of 26% was revised to 24% two years later.

Estrogen alone

Women who had had a hysterectomy were tested on estrogen alone. Bluming says they had no increased risk of breast cancer. Their rate was slightly lower, though not by enough to be statistically significant.

What changed since

In November 2025 the FDA removed the black box warning on hormone therapy, says Cynthia Guyer, a doctor at the Ultra Wellness Center, on Hyman's show. She adds that guidelines now say the benefits probably outweigh the risks for most women, especially those who start within five to ten years of their last period. Whether HRT is right for you is still a conversation with your clinician.

Related Questions

Was the WHI study wrong?
The speakers on tape call it misread, not wrong. Their point is the gap between a 26% relative rise and less than one extra case per 1,000 women a year, and no rise on estrogen alone. None of this counts toward a verdict yet.
What's the difference between relative and absolute risk in the WHI?
Relative risk compares two groups: 38 cases per 10,000 women a year against 30 is a 26% rise. Absolute risk is the gap itself, less than one extra case per 1,000 women a year.
Does the WHI still matter after the FDA dropped the warning?
The FDA removed the black box warning on hormone therapy in November 2025, a guest on Hyman's show says. Guidelines now say the benefits probably outweigh the risks for most women, she adds, especially those who start within five to ten years of their last period. The choice is still yours to make with your clinician.

More Questions About HRT & Menopause

Precis membership

Get the exact protocol for HRT & Menopause

The answer above is the whole answer: the verdict, every counted mention, where the sources disagree, and the receipt behind each one. Nothing on this page is held back.

A free account adds

  • Each dose named on the record, and the form named with it
  • Timing, and what to take it with or keep it away from
  • The interactions flagged by name

Pro adds

  • Chat answers drawn from 3,800+ hours of recorded interviews with 380+ researchers and doctors, plus 87,700+ research studies, each with a timecode
Go Pro — $9/mo or $79/yr

Full HRT & Menopause evidence report

The verdict on every claim, and where the sources disagree

How Precis checks a claim · Report an error